Oct 28HHS draft policy lets licensed pharmacies compound six peptides, including BPC-157. What changed and what did not.
Skip to content
PeptideAgent

Peptides for anxiety: what the evidence shows

By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed.  Last verified

At a glance

Selank is the only peptide with clinical trials in anxiety: small Russian trials against benzodiazepines, two of them randomized but unblinded, none placebo controlled, all from the developer's network, and not independently replicated; it is approved in Russia but not in the United States. Cognitive behavioral therapy and SSRI or SNRI antidepressants are the proven first line treatments.

Evidence: Strongest: Human RCT evidence2 peptides gradedVerified: Verified Sep 30, 2026

Do peptides help with anxiety disorders?

2 peptides are graded for anxiety disorders on this page. The strongest grade is human RCT evidence, for selank. Each one is weighed against the standard of care below, and the evidence table gives the grade and a note for every peptide.

What is the standard of care for anxiety disorders?

Cognitive behavioral therapy; SSRIs or SNRIs as first line medication; buspirone or pregabalin as alternatives; short term benzodiazepines only in selected cases; screen for depression, substance use, and medical causes such as thyroid disease.

Any peptide below should be judged against this baseline, not against doing nothing. Talk to a licensed provider before replacing or adding to an established treatment.

Which peptides have been studied for anxiety disorders?

Ordered by strength of evidence for this use. Grades follow the methodology; each peptide page lists the individual studies.

Peptides studied for Anxiety disorders with evidence grades
PeptideEvidence for this useNote
SelankEvidence: Human RCT evidenceTwo randomized but unblinded Russian trials compared selank with benzodiazepines: the anxiolytic effect was similar to medazepam in 62 patients, and adding selank to phenazepam in 70 patients brought earlier improvement and fewer benzodiazepine side effects; no placebo group, from the developer's network, and not independently replicated; not FDA approved. [1] [3]
NoopeptEvidence: Human observational evidenceA Russian comparison with piracetam reported improvement on anxiety measures alongside cognition, without a placebo arm; a dipeptide derived drug, not approved in the US. [5]

Head-to-head comparisons

Cost and access

Price ranges, lawful channels, and insurance notes for peptides graded here. State rules are in the legal guides by state.

Frequently asked questions

Are there peptides for anxiety?

Selank is the only peptide with clinical trials in anxiety, and they are weak: two randomized but unblinded Russian trials compared it with benzodiazepines and reported an effect similar to medazepam and fewer side effects when it was added to phenazepam, but neither had a placebo group, both come from the developer's network, and neither has been independently replicated. Noopept has one Russian comparison without a placebo arm. Neither is FDA approved. Cognitive behavioral therapy and SSRI or SNRI medication remain the first line treatments. [1] [3] [5] [6]

Is selank legal in the US?

There is no FDA approved or lawfully compounded US source today. Selank is not an FDA approved drug. FDA lists its nomination as withdrawn, so it is in no 503A category, it is not on the 503A bulks list, and it was not taken to FDA's July 2026 compounding advisory committee, so a pharmacy has no federal basis to compound it. [6] [7] [8]

Is any peptide FDA approved for anxiety disorders?

No. None of the peptides graded for anxiety disorders is an FDA approved drug, so any use is outside an approved label and depends on the compounding and research status shown on each peptide page. [6]

Has any peptide been tested in a randomized trial for anxiety disorders?

Yes, for selank. Check each note for the population and endpoints: a randomized trial in a related group or on a surrogate marker is weaker than one on the outcome you care about. [1] [3]

From the blog

Sources

  1. [1]Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurastheniaPubMed 18454096, 2008
  2. [2]A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disordersPubMed 25176261, 2014
  3. [3]Optimization of the treatment of anxiety disorders with selankPubMed 26356395, 2015
  4. [4]Peptide-based anxiolytics: the molecular aspects of heptapeptide selank biological activityPubMed 30255741, 2018
  5. [5]Comparative studies of Noopept and piracetam in the treatment of patients with mild cognitive disorders in organic brain diseases of vascular and traumatic originPubMed 19234797, 2009
  6. [6]Drugs@FDA: FDA-approved drugs databaseFDA
  7. [7]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA
  8. [8]FDA Pharmacy Compounding Advisory Committee meetings (July 2026 meeting on peptide nominations)FDA, 2026